M

Medicalgorithmics SA
WSE:MDG

Watchlist Manager
Medicalgorithmics SA
WSE:MDG
Watchlist
Price: 26.5 PLN -1.85% Market Closed
Market Cap: zł263.7m

EV/EBIT

-21.1
Current
21%
More Expensive
vs 3-y average of -17.3

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
-21.1
=
Enterprise Value
zł343.5m
/
EBIT
zł-13.3m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
-21.1
=
Enterprise Value
zł343.5m
/
EBIT
zł-13.3m

Valuation Scenarios

Medicalgorithmics SA is trading above its industry average

If EV/EBIT returns to its Industry Average (16), the stock would be worth zł-20.11 (176% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-176%
Maximum Upside
No Upside Scenarios
Average Downside
165%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple -21.1 zł26.5
0%
Industry Average 16 zł-20.11
-176%
Country Average 11.3 zł-14.18
-153%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
zł343.5m
/
Oct 2025
zł-13.3m
=
-21.1
Current
zł343.5m
/
Dec 2025
zł-10.2m
=
-33.6
Forward
zł343.5m
/
Dec 2026
zł5m
=
68.8
Forward
zł343.5m
/
Dec 2027
zł9.7m
=
35.3
Forward
zł343.5m
/
Dec 2028
zł16.5m
=
20.8
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
PL
Medicalgorithmics SA
WSE:MDG
268.7m PLN -21.1 -17.1
US
Intuitive Surgical Inc
NASDAQ:ISRG
171.7B USD 55.5 59.5
US
Abbott Laboratories
NYSE:ABT
159.2B USD 18.8 25.2
US
Stryker Corp
NYSE:SYK
126B USD 23.8 38.5
IE
Medtronic PLC
NYSE:MDT
106.8B USD 18.7 23.1
US
Boston Scientific Corp
NYSE:BSX
96.2B USD 26.7 33.7
DE
Siemens Healthineers AG
XETRA:SHL
41.6B EUR 15.3 19.2
US
Edwards Lifesciences Corp
NYSE:EW
47.3B USD 25.6 43
US
IDEXX Laboratories Inc
NASDAQ:IDXX
46.1B USD 32.9 42.1
US
Becton Dickinson and Co
NYSE:BDX
44.3B USD 16.8 25
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
32.5B USD 13.4 15.3

Market Distribution

Lower than 100% of companies in Poland
Percentile
0th
Based on 348 companies
0th percentile
-21.1
Low
0.5 — 8.1
Typical Range
8.1 — 16
High
16 —
Distribution Statistics
Poland
Min 0.5
30th Percentile 8.1
Median 11.3
70th Percentile 16
Max 313.7

Medicalgorithmics SA
Glance View

Market Cap
263.7m PLN
Industry
Health Care

Medicalgorithmics SA engages in the development of mobile electrocardiogram and arrhythmia diagnostic technology. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 329 full-time employees. The company went IPO on 2011-11-09. The firm develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). The company operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.

MDG Intrinsic Value
14.41 PLN
Overvaluation 46%
Intrinsic Value
Price zł26.5
M
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett